7SOL image
Entry Detail
PDB ID:
7SOL
Title:
Crystal Structures of the bispecific ubiquitin/FAT10 activating enzyme, Uba6
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2021-10-31
Release Date:
2022-11-02
Method Details:
Experimental Method:
Resolution:
2.25 Å
R-Value Free:
0.20
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Ubiquitin-like modifier-activating enzyme 6
Mutations:C625A
Chain IDs:A, C
Chain Length:1020
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Ubiquitin
Mutations:K6R, K11R, K27R, K29R, K33R, K48R, K63R
Chain IDs:B, D
Chain Length:83
Number of Molecules:2
Biological Source:Triticum aestivum
Primary Citation
Crystal structures reveal catalytic and regulatory mechanisms of the dual-specificity ubiquitin/FAT10 E1 enzyme Uba6.
Nat Commun 13 4880 4880 (2022)
PMID: 35986001 DOI: 10.1038/s41467-022-32613-5

Abstact

The E1 enzyme Uba6 initiates signal transduction by activating ubiquitin and the ubiquitin-like protein FAT10 in a two-step process involving sequential catalysis of adenylation and thioester bond formation. To gain mechanistic insights into these processes, we determined the crystal structure of a human Uba6/ubiquitin complex. Two distinct architectures of the complex are observed: one in which Uba6 adopts an open conformation with the active site configured for catalysis of adenylation, and a second drastically different closed conformation in which the adenylation active site is disassembled and reconfigured for catalysis of thioester bond formation. Surprisingly, an inositol hexakisphosphate (InsP6) molecule binds to a previously unidentified allosteric site on Uba6. Our structural, biochemical, and biophysical data indicate that InsP6 allosterically inhibits Uba6 activity by altering interconversion of the open and closed conformations of Uba6 while also enhancing its stability. In addition to revealing the molecular mechanisms of catalysis by Uba6 and allosteric regulation of its activities, our structures provide a framework for developing Uba6-specific inhibitors and raise the possibility of allosteric regulation of other E1s by naturally occurring cellular metabolites.

Legend

Protein

Chemical

Disease

Primary Citation of related structures